{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001787400","name":"Nkarta, Inc.","summary":"Nkarta, Inc. is a clinical-stage biopharmaceutical company developing allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. Its lead program, NKX019, is a CAR NK product candidate targeting CD19 for autoimmune diseases including lupus nephritis, systemic sclerosis, myositis, and ANCA-associated vasculitis. NKX019 is being studied in Phase 1 trials (Ntrust-1, Ntrust-2) and investigator-sponsored trials. The company operates cGMP manufacturing facilities in South San Francisco, California.","people":[],"products":[{"name":"NKX019","type":"platform","description":"Allogeneic CAR NK cell therapy targeting CD19 for autoimmune diseases including lupus nephritis, pMN, scleroderma, myositis, AAV, SLE, and myasthenia gravis."},{"name":"NKX101","type":"platform","description":"CAR NK product candidate targeting NKG2D ligand-expressing cells, previously studied in Phase 1 for hematologic malignancies; deprioritized in 2023."}],"partnerships":[{"partner_name":"Columbia University Irving Medical Center","partnership_type":"development","description":"Investigator-sponsored trial of NKX019 in patients with systemic lupus erythematosus (SLE).","start_date":null},{"partner_name":"University of California, Irvine","partnership_type":"development","description":"Investigator-sponsored trial of NKX019 in patients with myasthenia gravis, initiated May 2025.","start_date":null},{"partner_name":"University of Kansas Medical Center","partnership_type":"development","description":"Co-leading investigator-sponsored trial of NKX019 in patients with myasthenia gravis.","start_date":null}],"affiliations":[],"origin":{"leaf":"95530db771ae456850954a75b0128c8fb71a713a1b68091f228387b92f1b8bc4","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"e3c31a2fc6e0f7d0208b913ed20749357b1e71630c8a5d0af67d0a7b2282e9e2","parent":"3f41a6ab17a10449b3579acfb820f9e920c55591e9de8c9e01426821d65aa33a","source":"0001787400-26-000006","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":76,"hourly_limit":500,"remaining":424,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}